Blake Aftab - 05 Jul 2022 Form 4 Insider Report for Adicet Bio, Inc. (ACET)

Role
Chief Scientific Officer
Signature
/s/ Nick Harvey, Attorney-in-Fact
Issuer symbol
ACET
Transactions as of
05 Jul 2022
Net transactions value
-$19,764
Form type
4
Filing time
07 Jul 2022, 17:12:16 UTC
Previous filing
12 May 2022
Next filing
03 Aug 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ACET Common Stock Sale $19,764 -1,363 -2.5% $14.50* 52,903 05 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 Includes 1,363 shares purchased under the Issuer's Amended and Restated 2018 Employee Stock Purchase Plan on June 30, 2022 in a transaction that is exempt under Rule 16b-3(c) and 16b-3(d).